The most common method to detect HPV in OPSCC/HNSCC patients currently used in clinical practice and recommended by the AJCC and UICC TNM Committee is p16 IHC as a surrogate marker for HPV-related disease. The gene discussed is CDKN2A; the disease is head and neck squamous cell carcinoma.